Accuray Inc.: First Cancer Treatment With Robotic Solution in the USA and new Sales Record

Reading Time: 2 minutes
The company announced on August 13 that the first US customer will use the robot-based radiation treatment system Accuray Radixact to treat cancer patients. On August 14, the company also announced new record sales and its first profit in over a year in the fourth quarter of the 2024 financial year. CEO Suzanne Winter commented on the company's results: "We have received new product approvals, won important customers and started sales in new markets. These and other successes have enabled us to build a strong foundation for the growth of...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.